Toward an integrated discovery and development program in Alzheimer's disease: the amyloid hypothesis. - Suppr | 超能文献

Toward an integrated discovery and development program in Alzheimer's disease: the amyloid hypothesis.

作者信息

Greenberg B D, Murphy M F

机构信息

Cephalon, Inc., West Chester, PA 19380-4245.

出版信息

Neurobiol Aging. 1994;15 Suppl 2:S105-9. doi: 10.1016/0197-4580(94)90184-8.

DOI:10.1016/0197-4580(94)90184-8

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Toward an integrated discovery and development program in Alzheimer's disease: the amyloid hypothesis.

Neurobiol Aging. 1994;15 Suppl 2:S105-9. doi: 10.1016/0197-4580(94)90184-8.

2

[Molecular cytogenetic study and chromosome abnormalities in Alzheimer's disease. Protease-inhibitory peptides and amyloid beta protein in Alzheimer's disease].[阿尔茨海默病的分子细胞遗传学研究及染色体异常。阿尔茨海默病中的蛋白酶抑制肽与淀粉样β蛋白]

Nihon Rinsho. 1988 Jul;46(7):1514-20.

3

Novel therapy for Alzheimer's disease.阿尔茨海默病的新型疗法。

Neurobiol Aging. 1989 Sep-Oct;10(5):467-8; discussion 477-8. doi: 10.1016/0197-4580(89)90099-7.

4

Development of a new distyrylbenzene-derivative amyloid-β-aggregation and fibril formation inhibitor.新型二苯乙烯基苯衍生物淀粉样β蛋白聚集及原纤维形成抑制剂的研发

Chem Pharm Bull (Tokyo). 2012;60(9):1164-70. doi: 10.1248/cpb.c12-00365.

5

Amyloid Cascade into Clarity.淀粉样蛋白级联进入清晰状态。

Immunity. 2016 Oct 18;45(4):717-718. doi: 10.1016/j.immuni.2016.10.006.

6

Proceedings of the 10th International Conference on Alzheimer's Drug Discovery. September 14-15, 2009. Jersey City, New Jersey, USA.第十届国际阿尔茨海默病药物发现会议论文集。2009年9月14 - 15日。美国新泽西州泽西城。

Curr Alzheimer Res. 2010 May;7(3):188-279.

7

Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.针对淀粉样β肽的阿尔茨海默病免疫疗法的结构方面

Bratisl Lek Listy. 2018;119(4):201-204. doi: 10.4149/BLL_2018_037.

8

Drug discovery for Alzheimer's disease: filling the pipeline.阿尔茨海默病的药物研发：充实研发流程

Curr Alzheimer Res. 2007 Dec;4(5):501-2. doi: 10.2174/156720507783018172.

9

Pathways to Alzheimer's disease.阿尔茨海默病的发病途径。

J Intern Med. 2014 Mar;275(3):296-303. doi: 10.1111/joim.12192.

10

Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease.开发一种铂配合物作为治疗阿尔茨海默病的抗淀粉样蛋白药物。

Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3374-8. doi: 10.1002/anie.201209885. Epub 2013 Feb 10.

引用本文的文献

1

Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?阿尔茨海默病与血脑屏障功能——抗β-淀粉样蛋白疗法为何未能阻止痴呆症进展？

Neurosci Biobehav Rev. 2009 Jul;33(7):1099-108. doi: 10.1016/j.neubiorev.2009.05.006. Epub 2009 May 27.

2

Alzheimer's Abeta1-40 peptide modulates lipid synthesis in neuronal cultures and intact rat fetal brain under normoxic and oxidative stress conditions.阿尔茨海默病β淀粉样蛋白1-40肽在常氧和氧化应激条件下调节神经元培养物和完整大鼠胎脑中的脂质合成。

Neurochem Res. 2000 May;25(5):653-60. doi: 10.1023/a:1007511120099.